Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension

Pulmonary arterial hypertension (PAH) reflects abnormal pulmonary vascular resistance and causes right ventricular (RV) hypertrophy. Enhancement of the late sodium current (INaL) may result from hypertrophic remodelling. The study tests whether: (i) constitutive INaL enhancement may occur as part of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular research 2014-10, Vol.104 (1), p.37-48
Hauptverfasser: Rocchetti, Marcella, Sala, Luca, Rizzetto, Riccardo, Staszewsky, Lidia Irene, Alemanni, Matteo, Zambelli, Vanessa, Russo, Ilaria, Barile, Lucio, Cornaghi, Laura, Altomare, Claudia, Ronchi, Carlotta, Mostacciuolo, Gaspare, Lucchetti, Jacopo, Gobbi, Marco, Latini, Roberto, Zaza, Antonio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!